Home > Resources > Whitepapers > The Present and Future State of Synthetic Biology in Canada

The Present and Future State of Synthetic Biology in Canada

May 1, 2018

The synthetic biology community convened on March 6-7, 2018 at the “Canada Synbio 2018” Conference and Workshop as part of an ongoing effort to raise the profile and capacity of the synthetic biology community in Canada. The conference brought together a wide range of presenters and stakeholders in the interest not only of promoting and cultivating the synthetic biology community of practice, but also to begin establishing the common objectives and parameters for the field. As an emerging discipline at the cutting edge of technological development and scientific progress, synthetic biology is faced with an important set of challenges and opportunities in its process of continued development.

Spotlight

VICI

VICI Valco Instruments Co. Inc. has been the leading designer and manufacturer of standard and custom valves and fittings for precision analytical, biomedical, and biocompatible instrumentation.

OTHER WHITEPAPERS

Establishment of the basidiomycete Fomes fomentarius for the production of composite materials

whitePaper | February 24, 2022

Filamentous fungi of the phylum Basidiomycota are considered as an attractive source for the biotech‑ nological production of composite materials. The ability of many basidiomycetes to accept residual lignocellulosic plant biomass from agriculture and forestry.

Cell and Gene Therapy Clinical Trials

whitePaper | November 8, 2022

Using experienced-based best practices and documented tools, ICON has conducted over 63 CGT trials across multiple therapeutic areas from haematology-oncology torare and orphan diseases.

Quality Control Solutions for Cell and Gene Therapy

whitePaper | September 10, 2022

Droplet Digital PCR (ddPCR) provides highly precise and absolute quantification of nucleic acids by counting nucleic acid molecules encapsulated in discrete water-in-oil droplets.

The colors of life: an interdisciplinary artist-in-residence project to research fungal pigments as a gateway

whitePaper | January 10, 2022

Biological pigmentation is one of the most intriguing traits of many fungi. It holds signifcance to scientists, as a sign of biochemical metabolism and organism-environment interaction, and to artists, as the source of natural colors that capture the beauty of the microbial world.

Vendor Partnering in a Bioprocess Manufacturing and Supply Chain Ecosystem

whitePaper | August 30, 2022

Supply constancy, cost, sterility – even a subset of the factors that impact materials selection can be daunting for biopharmaceutical companies embark.

U.S. NATIONAL SCIENCE FOUNDATION

whitePaper | August 21, 2022

The “Government Performance and Results Act” and the “GPRA Modernization Act of 2010 require federal agencies to develop strategic plans setting forth long-term goals and objectives. Guidance.